NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat aging and age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional genomics, pooled perturbation screening, and artificial intelligence systems to unravel the biology of aging and disease using experiments of unprecedented scale.
DescriptionNewLimit is recruiting a Head of Technical Operations to lead drug substance and product chemistry, manufacturing, and controls (CMC). We are creating a new class of epigenetic reprogramming medicines for aging that build upon LNP and mRNA technology. Our initial assets are progressing through the complex manufacturing cascade that these modalities entail.
In this role, you will orchestrate manufacturing for some of the first reprogramming medicines to enter human trials. You will serve as the company’s resident expert in manufacturing & controls, and manage a team of talented scientists & engineers to achieve your goals.
As part of the role you will:
- Lead manufacturing campaigns for epigenetic reprogramming medicines spanning DNA, mRNA, and lipid nanoparticle manufacturing
- Own manufacturing timelines and deliverables for the world’s first reprogramming medicines
- Orchestrate contract manufacturing organizations, debug logistical issues, and keep timelines on track
- Manage and recruit talented scientists and engineers in drug substance and drug product teams
- Get in the lab and help teach, troubleshoot, and unblock projects
- Ph.D. in a natural science or engineering discipline (biology, chemistry; chemical engineering, industrial engineering) or B.S. and equivalent industry experience
- Experience leading drug substance or drug product manufacturing for nucleic acid therapies
- Experience supporting therapies through late preclinical and early clinical development
- Deep knowledge of mRNA drug substance manufacturing
- Experience managing a team of scientists or engineers
- Experience running a regulatory compliant manufacturing process or facility (GLP/GMP)
- Experience leading an LNP-mRNA therapy manufacturing campaign
- History of owning the CMC section of regulatory filings
Compensation for the role will depend on a number of factors, including a candidate’s qualifications, skills, competencies, and experience. NewLimit offers a competitive benefits package, which includes a 401k, healthcare coverage, and 20 days of PTO. Learn more at: https://www.newlimit.com/careers
Skills Required
- Ph.D. in a natural science or engineering discipline (biology, chemistry, chemical engineering, industrial engineering) OR B.S. with equivalent industry experience
- Experience leading drug substance or drug product manufacturing for nucleic acid therapies
- Experience supporting therapies through late preclinical and early clinical development
- Deep knowledge of mRNA drug substance manufacturing
- Experience managing a team of scientists or engineers
- Experience running a regulatory compliant manufacturing process or facility (GLP/GMP)
- Experience leading an LNP-mRNA therapy manufacturing campaign
- History of owning the CMC section of regulatory filings
What We Do
NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional genomics, pooled perturbation screening, and machine learning models to unravel the biology of epigenetic aging and disease using experiments of unprecedented scale.
